Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion type Assertion NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_head.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion description "[ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_provenance.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion evidence source_evidence_literature NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_provenance.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion SIO_000772 15867198 NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_provenance.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion wasDerivedFrom befree-2016 NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_provenance.
- NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_assertion wasGeneratedBy ECO_0000203 NP492675.RABkAoWtVJaBQtXhaff8ZvIn1LXyjvjMDs7u-F8GrgqLQ130_provenance.